Circulating omentin is associated with coronary artery disease in men.

[1]  J. Moreno-Navarrete,et al.  Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction , 2011, Obesity.

[2]  Peili Bu,et al.  Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. , 2011, Diabetes research and clinical practice.

[3]  J. Després,et al.  Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? , 2011, Journal of the American College of Cardiology.

[4]  M. Okada,et al.  Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. , 2011, Biochemical and biophysical research communications.

[5]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[6]  Yuichi Akasaki,et al.  Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.

[7]  J. Moreno-Navarrete,et al.  Circulating omentin concentration increases after weight loss , 2010, Nutrition & metabolism.

[8]  Qiang Li,et al.  Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. , 2010, Diabetes research and clinical practice.

[9]  M. Okada,et al.  Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. , 2010, Biochemical and biophysical research communications.

[10]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[11]  J. Després,et al.  Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk , 2009, Heart.

[12]  T. Murohara,et al.  Adiponectin and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[13]  H. Randeva,et al.  Omentin-1, a Novel Adipokine, Is Decreased in Overweight Insulin-Resistant Women With Polycystic Ovary Syndrome , 2008, Diabetes.

[14]  J. Gómez-Reino,et al.  Adipokines as emerging mediators of immune response and inflammation , 2007, Nature Clinical Practice Rheumatology.

[15]  A. Shuldiner,et al.  Omentin Plasma Levels and Gene Expression Are Decreased in Obesity , 2007, Diabetes.

[16]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[17]  S J Hurel,et al.  Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. , 2006, Atherosclerosis.

[18]  A. Shuldiner,et al.  Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. , 2006, American journal of physiology. Endocrinology and metabolism.

[19]  J. Schölmerich,et al.  Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. , 2005, Biochimica et biophysica acta.

[20]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[21]  S. L. Murphy,et al.  Deaths: final data for 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[22]  S. Kihara,et al.  Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.

[23]  J. Friedman.  A War on Obesity, Not the Obese , 2003, Science.

[24]  S. Devaraj,et al.  Role of C-reactive protein in the assessment of cardiovascular risk. , 2003, The American journal of cardiology.

[25]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[26]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[27]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[28]  K. Toyoshima,et al.  Human Intelectin Is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall* , 2001, The Journal of Biological Chemistry.

[29]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[30]  M. Jensen,et al.  Obesity and cardiovascular disease: is body structure a factor? , 1997, Current opinion in lipidology.

[31]  T Nakamura,et al.  Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.

[32]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.